Advances in targeted treatment for the heterogeneous bladder cancer population

Executive summary

Bladder cancer is one of oncology’s most complex diseases, marked by significant heterogeneity across genetic, histologic, and patient profiles. In this webinar, experts explore how precision oncology and Real-World Data (RWD) are driving advances in tailored treatment approaches. The discussion covers evolving precision therapies, the challenges of clinical validation, and how RWD is shaping more informed, personalized care decisions.

Key insights

• Real-world challenges and opportunities in data integration, clinical trials, and predictive modeling.
• The heterogeneity of bladder cancer and its impact on treatment selection.
• The evolution of precision medicine in oncology and emerging targeted therapies.
• The role of RWD in improving treatment strategies and supporting evidence-based clinical decisions.